Connect with us

Health

Eight months later: Researchers compare immune responses elicited by three COVID-19 vaccines – EurekAlert

In a paper published in the New England Journal of Medicine, a team of experts at Beth Israel Deaconess Medical Center compared…

Published

on

BOSTON – Based on the strength of clinical trial data showing the vaccines conferred robust protection against COVID-19, the U.S. Food & Drug Administration granted emergency use authorization to the mRNA-based vaccines known as BNT162b2 (BioNTech, Pfizer)…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending